Notice of Intent to Award to Sole Source -Microsphere, MagPlexAvidin, reg 026, 1ml

•The Centers for Disease Control and Prevention (CDC) intends to award a sole source, firm fixed price contract to LUMINEX CORP for purchase of Luminex LX200 instrument.

•This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1). The North American Industry Classification System code for this procurement is 541714 - Research and Development in Biotechnology (except Nanobiotechnology). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

•This notice of intent is not a request for competitive proposals; however, all responses received within three (3) days of the issuance of this notice will be considered by the government.  A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government.  Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.  Any quotation/response should be emailed to the  contract specialist Ruben Reyes at qmz3@cdc.gov by 12:00PM, September 06, 2024.

•The Luminex LX200 instrument is used in the DB Lab for immunodiagnostic research activities. The supplies and reagents requested from Luminex are exclusively designed and produced by the company to be used in Luminex instruments only.

•The Luminex LX200 instrument is used in the DB Lab for immunodiagnostic research activities. The supplies and reagents requested from Luminex are exclusively designed and produced by the company to be used in Luminex instruments only. No other products and services were considered for this request because only reagents and supplies designed and produced by Luminex may be used for the protocols that we will be running in the Luminex Platform in the DB lab.